VEGFA and acute myeloid leukemia: In conclusion, we identified for the first time IL8, IL13, and VEGFA SNPs as susceptibility biomarkers for AML and provided new insights about the possible role of these loci in modulating innate and adaptive immune responses, and thereby becoming potentially clinical targets for enhancement of the antileukemic effects of immune cells.